The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, January 03, 2018
The FDA has notified Palatin that it may proceed with its clinical investigation of subcutaneous injection PL-8177.
read more
Friday, December 29, 2017
Twice a year the federal government publishes the Unified Agenda which provides the American public with insight into regulations under development or...
read more
Thursday, December 28, 2017
Fervent Pharmaceuticals has submitted an IND application to the FDA for FP-101.
read more
Wednesday, December 27, 2017
NeuroRx has signed a Cooperative Research and Development Agreement with the U. S. Department of Veterans Affairs.
read more
Tuesday, December 26, 2017
Merck KGaA announced the FDA has granted Breakthrough Therapy Designation for avelumab in combination with INLYTA.
read more
Friday, December 22, 2017
Santen Pharmaceutical (Japan) and Santen (USA) announced the FDA has issued a complete response letter for the NDA for intravitreal sirolimus.
read more
Thursday, December 21, 2017
TARIS Biomedical and Bristol-Myers Squibb announced the companies have entered into a clinical trial collaboration to evaluate TAR-200.
read more
Thursday, December 21, 2017
Array BioPharma has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-...
read more
Wednesday, December 20, 2017
EpiVax announced their latest development program for novel antigen-specific therapies, an approach which may have applications across a range of ...
read more
Wednesday, December 20, 2017
Bayer announced its collaboration partner Loxo Oncology has initiated the submission of a rolling NDA to the FDA for larotrectinib.
read more
Tuesday, December 19, 2017
In recent years, the medical community has experienced a shift in the way health care is practiced.
read more
Tuesday, December 19, 2017
Second Genome has successfully completed a Phase 1 study in healthy volunteers for its lead therapeutic candidate, SGM-1019.
read more
Tuesday, December 19, 2017
ClearPath has initiated a third research collaboration with Astellas Pharma to combat infections.
read more
Monday, December 18, 2017
RXi Pharmaceuticals announced positive results with its lead clinical compound RXI-109 in a Phase 2 clinical trial.
read more
Friday, December 15, 2017
Egalet announced the FDA has granted tentative approval for an expanded label for ARYMO ER tablets C-II for long-term pain management.
read more